| Uveal effusion induced by topical travoprost in a patient with Sturge-Weber-Krabbe syndrome. | |
| | |
MedLine Citation:
|
PMID: 19107053 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE: To report a case of uveal effusion with subtotal exudative retinal detachment induced by topical administration of travoprost. CASE REPORT: A 20-year-old woman with a medical history of right-sided Sturge-Weber-Krabbe syndrome and bilateral aphakia secondary to congenital cataract extraction was referred to our department for retinal detachment associated with uveal effusion of the right eye. The ocular manifestations of Sturge-Weber-Krabbe syndrome in her right eye were glaucoma and diffuse choroidal hemangioma. Antiglaucomatous medications using topical travoprost 0.004%/timolol 0.5% (fixed combination) had been begun 1 week before. An adverse effect of travoprost was suspected and the drug was discontinued. Three weeks later, a fundus examination showed total disappearance of the uveal effusion. CONCLUSIONS: Interaction of the effects of topical prostaglandin analogs (blood-aqueous barrier disruption, enhancement of uveoscleral outflow) with both the diffuse choroidal hemangioma and the elevated episcleral venous pressure may lead to uveal effusion in Sturge-Weber-Krabbe syndrome. In spite of their efficiency, prostaglandin F2 analogs (latanoprost, travoprost and bimatoprost) should be used with caution in Sturge-Weber-Krabbe syndrome and particularly in cases of proved diffuse choroidal hemangioma. |
| | |
Authors:
|
J Gambrelle; P Denis; V Kocaba; J D Grange |
Related Documents
:
|
16146483 - Anaesthetic management of osler-weber-rendu syndrome with coexisting congenital methaem... 8770273 - Choroid plexus size in young children with sturge-weber syndrome. 20614493 - Isolated ileal perforation due to cytomegalovirus reactivation during management of ter... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal fran?ais d'ophtalmologie Volume: 31 ISSN: 1773-0597 ISO Abbreviation: J Fr Ophtalmol Publication Date: 2008 Nov |
Date Detail:
|
Created Date: 2008-12-24 Completed Date: 2009-10-28 Revised Date: 2010-03-24 |
Medline Journal Info:
|
Nlm Unique ID: 7804128 Medline TA: J Fr Ophtalmol Country: France |
Other Details:
|
Languages: eng Pagination: e19 Citation Subset: IM |
Affiliation:
|
Service d'Ophtalmologie, H?pital de la Croix-Rousse - Hospices Civils de Lyon, Lyon. joel.gambrelle@chu-lyon.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Topical Antihypertensive Agents / administration & dosage*, adverse effects* Body Fluids Cloprostenol / administration & dosage, adverse effects, analogs & derivatives* Female Humans Retinal Detachment / chemically induced* Sturge-Weber Syndrome / complications* Uveal Diseases / chemically induced* Young Adult |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents; 157283-68-6/travoprost; 40665-92-7/Cloprostenol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Advantages of corticosteroids in managing acute bacterial postoperative endophthalmitis
Next Document: Optical coherence tomography: a reliable tool for localisation of macular hemorrhage. Two case repor...